Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDTRA-RSA-2
CompoundTramadol
Trials sponsorGrünenthal GmbH
Trial phase3
Brief titleEvaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability
IndicationPain in Children, dental extractions
UTN
CTG ID
CTIS ID (former EudraCT)Paediatric studies in scope of Art45 document reference 44997
Trial statusCompleted
FPIJuly 30, 2001
LPOFebruary 28, 2003
CountriesBelgium, Czechia, France, Germany, Netherlands, Poland, Spain, Switzerland
GenderAll
Age18 and 80 years
ResultsNo
Pubmed
Documents
TRA-RSA-2 | Grünenthal